Back in 2014 and 2015, when RGBP actually had real scientists working for them, they did eight presentations at international conferences and symposiums covering their entire pipeline. I'm pretty sure that BP is well aware of what RGBP has. If any of it had any value don't you think they would have made some offers? They didn't become Big Pharma by having their heads in the sand. The dates and topics of the presentations are on the company websight. Due Diligence.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.